SCA
PFE icon

Stonebridge Capital Advisors’s Pfizer PFE Stock Holding History

Stonebridge Capital Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$561K Sell
19,985
-409
-2% -$10.9K 0.04% 139
2025
Q4 		$508K Sell
20,394
-64
-0.3% -$1.61K 0.04% 132
2025
Q3 		$521K Sell
20,458
-2,873
-12% -$70.9K 0.04% 132
2025
Q2 		$566K Sell
23,331
-861
-4% -$20.1K 0.04% 128
2025
Q1 		$613K Buy
24,192
+2,127
+10% +$55.7K 0.05% 121
2024
Q4 		$585K Sell
22,065
-4,562
-17% -$124K 0.05% 126
2024
Q3 		$771K Sell
26,627
-2,316
-8% -$67.6K 0.06% 118
2024
Q2 		$810K Buy
28,943
+2,357
+9% +$64.9K 0.07% 115
2024
Q1 		$738K Buy
26,586
+6,921
+35% +$192K 0.07% 127
2023
Q4 		$566K Sell
19,665
-2,092
-10% -$63.2K 0.06% 132
2023
Q3 		$722K Sell
21,757
-841
-4% -$29.7K 0.08% 127
2023
Q2 		$829K Buy
22,598
+898
+4% +$35K 0.09% 122
2023
Q1 		$885K Buy
21,700
+260
+1% +$11.2K 0.1% 120
2022
Q4 		$1.1M Sell
21,440
-101
-0.5% -$4.84K 0.13% 111
2022
Q3 		$943K Buy
21,541
+300
+1% +$14.6K 0.12% 118
2022
Q2 		$1.11M Sell
21,241
-899
-4% -$45.8K 0.14% 114
2022
Q1 		$1.15M Sell
22,140
-2,828
-11% -$147K 0.12% 115
2021
Q4 		$1.47M Buy
24,968
+1,290
+5% +$63.9K 0.16% 106
2021
Q3 		$1.02M Sell
23,678
-23,937
-50% -$1.06M 0.12% 116
2021
Q2 		$1.79M Buy
47,615
+23,655
+99% +$920K 0.11% 117
2021
Q1 		$868K Sell
23,960
-1,005
-4% -$35.7K 0.11% 115
2020
Q4 		$919K Sell
24,965
-184
-0.7% -$6.75K 0.14% 112
2020
Q3 		$876K Buy
25,149
+643
+3% +$22.5K 0.16% 105
2020
Q2 		$760K Sell
24,506
-554
-2% -$18.8K 0.14% 107
2020
Q1 		$776K Sell
25,060
-1,731
-6% -$59K 0.16% 103
2019
Q4 		$996K Buy
26,791
+591
+2% +$21.1K 0.16% 106
2019
Q3 		$893K Buy
26,200
+694
+3% +$25.2K 0.15% 109
2019
Q2 		$1.05M Buy
25,506
+303
+1% +$12K 0.19% 106
2019
Q1 		$1.02M Buy
25,203
+1,094
+5% +$43.8K 0.19% 109
2018
Q4 		$998K Sell
24,109
-486
-2% -$20.2K 0.23% 90
2018
Q3 		$1.03M Hold
24,595
– – 0.21% 96
2018
Q2 		$847K Sell
24,595
-307
-1% -$10.5K 0.18% 100
2018
Q1 		$839K Buy
24,902
+1,015
+4% +$34.9K 0.19% 101
2017
Q4 		$821K Sell
23,887
-37,242
-61% -$1.27M 0.19% 102
2017
Q3 		$2.07M Buy
61,129
+457
+0.8% +$14.7K 0.51% 66
2017
Q2 		$1.93M Buy
60,672
+1,836
+3% +$57.9K 0.51% 68
2017
Q1 		$1.91M Buy
58,836
+5,076
+9% +$160K 0.52% 66
2016
Q4 		$1.66M Buy
53,760
+4,693
+10% +$143K 0.49% 74
2016
Q3 		$1.58M Buy
49,067
+10,987
+29% +$367K 0.49% 72
2016
Q2 		$1.27M Buy
38,080
+4,421
+13% +$141K 0.43% 79
2016
Q1 		$946K Buy
33,659
+8,696
+35% +$248K 0.33% 87
2015
Q4 		$764K Buy
24,963
+1,783
+8% +$56.1K 0.28% 92
2015
Q3 		$691K Sell
23,180
-1,538
-6% -$49.3K 0.28% 94
2015
Q2 		$786K Buy
24,718
+1,422
+6% +$46.3K 0.3% 90
2015
Q1 		$769K Buy
23,296
+5,692
+32% +$181K 0.3% 91
2014
Q4 		$520K Buy
17,604
+1,107
+7% +$31.7K 0.21% 105
2014
Q3 		$463K Buy
16,497
+2,843
+21% +$79.8K 0.2% 99
2014
Q2 		$384K Buy
13,654
+422
+3% +$12K 0.17% 108
2014
Q1 		$403K Buy
13,232
+422
+3% +$12.6K 0.2% 105
2013
Q4 		$372K Buy
+12,810
New +$373K 0.19% 106

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Stonebridge Capital Advisors's PFE Position: Q1 2026 in Review

Stonebridge Capital Advisors reduced its Pfizer (PFE) stake by 2% in Q1 2026, selling an estimated $10.9K and leaving 19,985 shares worth $561K. The position accounts for 0.04% of the portfolio, ranked #139.

Stonebridge Capital Advisors first reported a position in PFE in Q4 2013 and has held it in 50 quarters since. The position peaked at $2.07M in Q3 2017. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Stonebridge Capital Advisors held 19,985 shares of Pfizer worth $561K as of Q1 2026.
  • Stonebridge Capital Advisors sold 409 Pfizer shares in Q1 2026, an estimated $10.9K.
  • Pfizer made up 0.04% of Stonebridge Capital Advisors's portfolio in Q1 2026, its #139 holding.
  • Stonebridge Capital Advisors first reported a position in Pfizer in Q4 2013 and has held it in 50 quarters since.
  • Stonebridge Capital Advisors's Pfizer position peaked at $2.07M in Q3 2017.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Stonebridge Capital Advisors's 13F filing for Q1 2026, filed 14 May 2026.